<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Noninvasive assessment of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> (ED) and diagnosing the early vascular development of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in active mucocutaneous <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-nine active BD patients (study group) without any obstructive vascular involvement were compared with twenty-nine healthy controls (control group) in terms of ED utilizing endothelium-dependent dilation as well as endothelium-independent dilation (FMD), which was assessed by measuring changes in brachial artery diameter following sublingual glyceril trinitrate (400 microg <z:chebi fb="0" ids="28787">Nitrolingual</z:chebi> spray) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent a complete transthoracic echocardiographic and tissue Doppler study </plain></SENT>
<SENT sid="3" pm="."><plain>A standard form was utilized for the documentation of the presence or absence of the known risk factors for atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Statistical analysis was performed by utilizing SPSS version 11 </plain></SENT>
<SENT sid="5" pm="."><plain>There was no difference between patients and controls in terms of echocardiographic and tissue Doppler parameters as well as baseline brachial artery diameters </plain></SENT>
<SENT sid="6" pm="."><plain>Flow-mediated dilation showed 38% impairment in study group compared with control (P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Endothelium-independent NTG <z:mpath ids='MPATH_66'>dilatation</z:mpath> did not differ in both groups </plain></SENT>
<SENT sid="8" pm="."><plain>Ultrasonography is an easily applicable noninvasive method for following BD patients for the risk of ED, which may preclude to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, save time and cost-effective </plain></SENT>
</text></document>